恢复期血浆在急性病毒性传染病中的应用现状及在新冠肺炎治疗中的应用前景

Q4 Immunology and Microbiology

中国生物制品学杂志 Pub Date : 2020-01-01 DOI:10.13200/j.cnki.cjb.003023

X. M. Yang, J. Hou

{"title":"恢复期血浆在急性病毒性传染病中的应用现状及在新冠肺炎治疗中的应用前景","authors":"X. M. Yang, J. Hou","doi":"10.13200/j.cnki.cjb.003023","DOIUrl":null,"url":null,"abstract":"With the successful application of convalescent plasma (CP) in various acute viral infectious diseases, the unique advantage of the therapy has been paid more and more attentions Recently, a novel coronavirus named as 2019-nCoV (SARS-CoV-2) was discovered and identified in Wuhan, China Up to now, there has been no specific treatment for 2019-nCoV (SARS-CoV-2) infection This paper describes the current status of application of CP in Ebola, pandemic influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) as well as the prospect of CP in therapy of COVID-19","PeriodicalId":9990,"journal":{"name":"中国生物制品学杂志","volume":"28 1","pages":"241-245"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Current status of application of convalescent plasma in acute viral infectious diseases and its prospect in therapy of COVID-19\",\"authors\":\"X. M. Yang, J. Hou\",\"doi\":\"10.13200/j.cnki.cjb.003023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With the successful application of convalescent plasma (CP) in various acute viral infectious diseases, the unique advantage of the therapy has been paid more and more attentions Recently, a novel coronavirus named as 2019-nCoV (SARS-CoV-2) was discovered and identified in Wuhan, China Up to now, there has been no specific treatment for 2019-nCoV (SARS-CoV-2) infection This paper describes the current status of application of CP in Ebola, pandemic influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) as well as the prospect of CP in therapy of COVID-19\",\"PeriodicalId\":9990,\"journal\":{\"name\":\"中国生物制品学杂志\",\"volume\":\"28 1\",\"pages\":\"241-245\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国生物制品学杂志\",\"FirstCategoryId\":\"1089\",\"ListUrlMain\":\"https://doi.org/10.13200/j.cnki.cjb.003023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Immunology and Microbiology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国生物制品学杂志","FirstCategoryId":"1089","ListUrlMain":"https://doi.org/10.13200/j.cnki.cjb.003023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}

引用次数: 1

摘要

随着恢复期血浆(CP)在各种急性病毒性传染病中的成功应用，其独特的治疗优势越来越受到人们的重视。最近，在中国武汉发现并鉴定了一种名为2019-nCoV (SARS-CoV-2)的新型冠状病毒。到目前为止，还没有针对2019-nCoV (SARS-CoV-2)感染的特异性治疗方法。严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)，以及CP治疗COVID-19的前景

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Current status of application of convalescent plasma in acute viral infectious diseases and its prospect in therapy of COVID-19

With the successful application of convalescent plasma (CP) in various acute viral infectious diseases, the unique advantage of the therapy has been paid more and more attentions Recently, a novel coronavirus named as 2019-nCoV (SARS-CoV-2) was discovered and identified in Wuhan, China Up to now, there has been no specific treatment for 2019-nCoV (SARS-CoV-2) infection This paper describes the current status of application of CP in Ebola, pandemic influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) as well as the prospect of CP in therapy of COVID-19

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

中国生物制品学杂志 Immunology and Microbiology-Applied Microbiology and Biotechnology

CiteScore

0.20

自引率

0.00%

发文量

7597